PML and neoplasm: There is also a related study that a CK2 inhibitor regulates tumor phenotype by influencing the location of Zinc Finger CCCH-Type Containing (ZC3H8) protein at both promyelocytic leukemia (PML) bodies and Cajal bodies within the nucleus [37].